HbA1c (glycated hemoglobin) is a well-established biomarker reflecting average blood glucose levels over the preceding 8–12 weeks. It forms when glucose binds non-enzymatically to hemoglobin in red blood cells. Clinically, HbA1c is used to diagnose and monitor diabetes mellitus. Elevated levels correlate with increased risk of diabetic complications. However, HbA1c has limitations: it can be skewed by anemia, kidney disease, hemoglobin variants (e.g., sickle cell), or pregnancy. It does not capture short-term glucose fluctuations or postprandial spikes. For non-diabetic individuals, HbA1c is less sensitive than fasting glucose or oral glucose tolerance tests. In home test kits, HbA1c is available but should be interpreted by a healthcare professional. In summary, HbA1c is a useful tool for long-term glucose control but not a standalone indicator for daily blood sugar management. Evidence: strong clinical studies (human-strong).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-dd5d30944de23190737c9850